Company: LGNZZ
Filing Date: 2025-02-27
Form Type: 8-K
Source: 0000886163-25-000008
Chunk: 1

Company: LIGAND PHARMACEUTICALS INC
Filing Date: 2025-02-27
Form: 8-K
Item: Item 9.01
Chunk 1
---
Item 9.01 Financial Statements and Exhibits.

(d) Exhibits.

  Exhibit No.      Description                             
         99.1      Press release dated February 27, 2025.  
 ───────────────────────────────────────────────────────────

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, as amended, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

                               LIGAND PHARMACEUTICALS INCORPORATED       
  Date: February 27, 2025      By: /s/ Andrew Reardon